Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia

NCT01460693 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

814

Enrollment

OTHER

Sponsor class

Conditions

Myeloid Leukemia, Chronic, Chronic Phase

Interventions

DRUG: Imatinib
DRUG: Dasatinib

Sponsor

Newcastle University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]